Tuberculosis, Lymph Node: Clinical Trials

1 trial for Tuberculosis, Lymph Node, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Tuberculosis, Lymph Node: new trials by email Literature Review of Tuberculosis, Lymph Node trials Research Report on Tuberculosis, Lymph Node

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Shortened Regimen for Drug-susceptible TB in Children
Isoniazid, Rifampin, Pyrazinamide - Tuberculosis, Tuberculosis, Pulmonary
Phase 3RecruitingJohns Hopkins University8602025-01-152026-07-24

Narrower conditions

Infections (1)  ·  Lung Diseases (1)  ·  Mycobacterium Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Tuberculosis (1)  ·  Tuberculosis, Pulmonary (1)

Broader conditions

Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Tuberculosis, Extrapulmonary (1)

Interventions

Ethambutol (1)  ·  Isoniazid (1)  ·  Moxifloxacin (1)  ·  Protons (1)  ·  Pyrazinamide (1)  ·  Rifampin (1)  ·  rifapentine (1)

Sponsors

Johns Hopkins University (1)

Countries

India (1)  ·  Indonesia (1)  ·  Mozambique (1)  ·  South Africa (1)  ·  Uganda (1)  ·  Zambia (1)  ·  Zimbabwe (1)

Top investigators

Nicole Salazar-Austin, MD, ScM (1)